109 related articles for article (PubMed ID: 6823406)
1. Immunological response to tumor ischemia in a murine renal cell carcinoma model.
Edson Pontes J; Goldrosen M; Murphy GP
Oncology; 1983; 40(1):63-6. PubMed ID: 6823406
[No Abstract] [Full Text] [Related]
2. Immunologic therapies of kidney carcinoma.
McCune CS
Semin Oncol; 1983 Dec; 10(4):431-6. PubMed ID: 6198729
[No Abstract] [Full Text] [Related]
3. In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic immune RNA treatment of patients with widespread melanoma or metastatic renal cell carcinoma.
Steele G; Wang BS; Richie J; Wilson RE; Ervin T; Yankee R; Fallon M; Mannick JA
Cancer Res; 1980 Jul; 40(7):2377-82. PubMed ID: 6155992
[No Abstract] [Full Text] [Related]
4. Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease.
Salup RR; Wiltrout RH
Cancer Immunol Immunother; 1986; 22(1):31-6. PubMed ID: 3486715
[TBL] [Abstract][Full Text] [Related]
5. Proceedings: Current results from treatment of renal cell carcinoma.
Murphy GP
Proc Natl Cancer Conf; 1972; 7():751-9. PubMed ID: 4587662
[No Abstract] [Full Text] [Related]
6. Immunotherapy of a murine renal cancer.
Huben RP; Connelly R; Goldrosen MH; Murphy GP; Pontes JE
J Urol; 1983 May; 129(5):1075-8. PubMed ID: 6854757
[TBL] [Abstract][Full Text] [Related]
7. [Renal adenocarcinoma treated with regressor plasma].
Hippe E; Hvidt V; Jensen A; Lauridsen L
Ugeskr Laeger; 1976 Jul; 138(28):1689-92. PubMed ID: 936322
[No Abstract] [Full Text] [Related]
8. Unilateral nephrectomy. Its effect on primary murine renal adenocarcinoma.
Williams PD; Bhanalaph T; Murphy GP
Urology; 1973 Dec; 2(6):619-22. PubMed ID: 4766018
[No Abstract] [Full Text] [Related]
9. A murine renal cell carcinoma.
Murphy GP; Hrushesky WJ
J Natl Cancer Inst; 1973 Apr; 50(4):1013-25. PubMed ID: 4703766
[No Abstract] [Full Text] [Related]
10. Advanced renal cell carcinoma: treatment with xenogeneic immune ribonucleic acid and appropriate surgical resection.
Skinner DG; Dekernion JB; Brower PA; Ramming KP; Pilch YH
J Urol; 1976 Mar; 115(3):246-50. PubMed ID: 943577
[TBL] [Abstract][Full Text] [Related]
11. Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model.
Matin SF; Sharma P; Gill IS; Tannenbaum C; Hobart MG; Novick AC; Finke JH
J Urol; 2010 Jan; 183(1):333-8. PubMed ID: 19914660
[TBL] [Abstract][Full Text] [Related]
12. The role of embolization and nephrectomy in the treatment of metastatic renal carcinoma.
Swanson DA; Wallace S; Johnson DE
Urol Clin North Am; 1980 Oct; 7(3):719-30. PubMed ID: 7456183
[No Abstract] [Full Text] [Related]
13. Influence of tumor site on the therapy of murine kidney cancer.
Chakrabarty A; Hillman GG; Maughan RL; Visscher DW; Ali E; Pontes JE; Haas GP
Anticancer Res; 1994; 14(2A):373-8. PubMed ID: 8017836
[TBL] [Abstract][Full Text] [Related]
14. Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine model.
Kroeze SG; Daenen LG; Nijkamp MW; Roodhart JM; de Gast GC; Bosch JL; Jans JJ
J Urol; 2012 Aug; 188(2):607-14. PubMed ID: 22704448
[TBL] [Abstract][Full Text] [Related]
15. Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response.
Coleman M; Muller S; Quezada A; Mendiratta SK; Wang J; Thull NM; Bishop J; Matar M; Mester J; Pericle F
Hum Gene Ther; 1998 Oct; 9(15):2223-30. PubMed ID: 9794206
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of cancer: an experimental model in syngeneic guinea pigs.
Kronman BS; Wepsic HT; Churchill WH; Zbar B; Borsos T; Rapp HJ
Science; 1970 Apr; 168(3928):257-9. PubMed ID: 5418645
[TBL] [Abstract][Full Text] [Related]
17. [Different immunological factors in the therapy of an experimental tumor].
Nicolin A; Frontini E; Olivani P
Boll Ist Sieroter Milan; 1971; 50(4):295-8. PubMed ID: 5163498
[No Abstract] [Full Text] [Related]
18. Adoptive immunotherapy in combination with chemotherapy for cancer treatment.
Wiltrout RH; Salup RR
Prog Exp Tumor Res; 1988; 32():128-53. PubMed ID: 3287448
[No Abstract] [Full Text] [Related]
19. An immunological approach to the therapy of cancer?
Horn L; Horn HL
Lancet; 1971 Aug; 2(7722):466-9. PubMed ID: 4105332
[No Abstract] [Full Text] [Related]
20. Effects on tumor growth in vivo by manipulation of the tumor immune response.
Sjögren HO
Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
